Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.
June 24, 2021
Synthetic control arms (SCAs) leverage real world data from various sources or evaluations of historical clinical data...
Read article
August 7, 2020
Creating a Synthetic Control from Your Natural History Study
Recently a biotech approached Cytel for support with a Phase 2 Study in oncology. Regulators had requested a natural...
Read article
February 25, 2020
Bayesian Methods for Contending with Homogeneity and Heterogeneity in Real World Data
Over the past decade, a new trend began to emerge, changing the way that clinical trials are conducted. Whereas...
Read article
February 25, 2020
Ensuring an Unbiased Comparator Arm
Regulators in both the United States and Europe have responded positively to the use of SCAs in clinical...
Read article
December 10, 2019
Impact of AI on Clinical Development
In association with Statisticians in the Pharmaceutical Industry (PSI) , UCB and Cytel hosted a symposium on September...
Read article